Blueprint Medicines(BPMC) - 2023 Q4 - Earnings Call Transcript

Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Conference Call February 15, 2024 8:00 AM ET Company Participants Jenna Cohen - Vice President, Investor Relations Kate Haviland - Chief Executive Officer Philina Lee - Chief Commercial Officer Suad Namouni - President of Research and Development Christy Rossi - Chief Operating Officer Mike Landsittel - Chief Financial Officer Becker Hewes - Chief Medical Officer Conference Call Participants Brad Canino - Stifel Salveen Richter - Goldman Sachs ...